-+ 0.00%
-+ 0.00%
-+ 0.00%

Jade Biosciences Q4 EPS $(0.11) Beats $(0.49) Estimate

Benzinga·03/06/2026 13:06:28
Listen to the news
Jade Biosciences (NASDAQ:JBIO) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.49) by 77.64 percent.